Home/Filings/4/0001192482-16-000723
4//SEC Filing

Tabula Rasa HealthCare, Inc. 4

Accession 0001192482-16-000723

CIK 0001651561operating

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:26 PM ET

Size

21.6 KB

Accession

0001192482-16-000723

Insider Transaction Report

Form 4
Period: 2016-10-04
Transactions
  • Conversion

    Series A Preferred Stock

    2016-10-04916,7660 total
    Common Stock (472,560 underlying)
  • Conversion

    Common Stock

    2016-10-04+53,912866,789 total
  • Conversion

    Series A-1 Preferred Stock

    2016-10-04587,1580 total
    Common Stock (302,659 underlying)
  • Conversion

    Common Stock

    2016-10-04+472,560510,218 total
  • Conversion

    Series B Preferred Stock

    2016-10-04104,5890 total
    Common Stock (53,912 underlying)
  • Conversion

    Common Stock

    2016-10-04+302,659812,877 total
Transactions
  • Conversion

    Common Stock

    2016-10-04+302,659812,877 total
  • Conversion

    Series A-1 Preferred Stock

    2016-10-04587,1580 total
    Common Stock (302,659 underlying)
  • Conversion

    Common Stock

    2016-10-04+472,560510,218 total
  • Conversion

    Common Stock

    2016-10-04+53,912866,789 total
  • Conversion

    Series A Preferred Stock

    2016-10-04916,7660 total
    Common Stock (472,560 underlying)
  • Conversion

    Series B Preferred Stock

    2016-10-04104,5890 total
    Common Stock (53,912 underlying)
BRESSNER GLEN R
Director10% Owner
Transactions
  • Conversion

    Series B Preferred Stock

    2016-10-04104,5890 total
    Common Stock (53,912 underlying)
  • Conversion

    Common Stock

    2016-10-04+472,560510,218 total
  • Conversion

    Common Stock

    2016-10-04+53,912866,789 total
  • Conversion

    Series A-1 Preferred Stock

    2016-10-04587,1580 total
    Common Stock (302,659 underlying)
  • Conversion

    Common Stock

    2016-10-04+302,659812,877 total
  • Conversion

    Series A Preferred Stock

    2016-10-04916,7660 total
    Common Stock (472,560 underlying)
Arnson Eric R
10% Owner
Transactions
  • Conversion

    Common Stock

    2016-10-04+302,659812,877 total
  • Conversion

    Series B Preferred Stock

    2016-10-04104,5890 total
    Common Stock (53,912 underlying)
  • Conversion

    Common Stock

    2016-10-04+472,560510,218 total
  • Conversion

    Common Stock

    2016-10-04+53,912866,789 total
  • Conversion

    Series A-1 Preferred Stock

    2016-10-04587,1580 total
    Common Stock (302,659 underlying)
  • Conversion

    Series A Preferred Stock

    2016-10-04916,7660 total
    Common Stock (472,560 underlying)
Transactions
  • Conversion

    Series A Preferred Stock

    2016-10-04916,7660 total
    Common Stock (472,560 underlying)
  • Conversion

    Series B Preferred Stock

    2016-10-04104,5890 total
    Common Stock (53,912 underlying)
  • Conversion

    Common Stock

    2016-10-04+302,659812,877 total
  • Conversion

    Common Stock

    2016-10-04+472,560510,218 total
  • Conversion

    Common Stock

    2016-10-04+53,912866,789 total
  • Conversion

    Series A-1 Preferred Stock

    2016-10-04587,1580 total
    Common Stock (302,659 underlying)
Footnotes (3)
  • [F1]Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.
  • [F2]This report is filed jointly by Originate #1A, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.
  • [F3]All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

Issuer

Tabula Rasa HealthCare, Inc.

CIK 0001651561

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001651561

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:26 PM ET
Size
21.6 KB